These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 11973634
1. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model. Moriuchi S, Wolfe D, Tamura M, Yoshimine T, Miura F, Cohen JB, Glorioso JC. Gene Ther; 2002 May; 9(9):584-91. PubMed ID: 11973634 [Abstract] [Full Text] [Related]
2. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Kim JH, Kolozsvary A, Rogulski K, Khil MS, Brown SL, Freytag SO. Cancer J Sci Am; 1998 May; 4(6):364-9. PubMed ID: 9853135 [Abstract] [Full Text] [Related]
3. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC. Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368 [Abstract] [Full Text] [Related]
4. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Xie Y, Gilbert JD, Kim JH, Freytag SO. Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364 [Abstract] [Full Text] [Related]
5. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE. Cancer Res; 1995 Nov 01; 55(21):4808-12. PubMed ID: 7585511 [Abstract] [Full Text] [Related]
6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS. Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394 [Abstract] [Full Text] [Related]
7. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K. J Gene Med; 2004 Mar 15; 6(3):288-99. PubMed ID: 15026990 [Abstract] [Full Text] [Related]
8. Killing effect of coexpressing cytosine deaminase and thymidine kinase on rat vascular smooth muscle cells. Cao HQ, Meng XM, Liu DQ, Zhao XW, Ding JF. Chin Med J (Engl); 2004 Oct 15; 117(10):1464-70. PubMed ID: 15498366 [Abstract] [Full Text] [Related]
9. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity. Lee YJ, Lee H, Borrelli MJ. Cancer Gene Ther; 2002 Mar 15; 9(3):267-74. PubMed ID: 11896443 [Abstract] [Full Text] [Related]
10. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA. Cancer Res; 1994 Nov 15; 54(22):5745-51. PubMed ID: 7954393 [Abstract] [Full Text] [Related]
11. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Namba H, Tagawa M, Miyagawa T, Iwadate Y, Sakiyama S. Cancer Gene Ther; 2000 Jun 15; 7(6):947-53. PubMed ID: 10880027 [Abstract] [Full Text] [Related]
12. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy. Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM, Marino R, Glorioso JC, Yoshimine T. Gene Ther; 2002 Dec 15; 9(24):1653-8. PubMed ID: 12457278 [Abstract] [Full Text] [Related]
13. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase. Rogers RP, Ge JQ, Holley-Guthrie E, Hoganson DK, Comstock KE, Olsen JC, Kenney S. Hum Gene Ther; 1996 Dec 01; 7(18):2235-45. PubMed ID: 8953314 [Abstract] [Full Text] [Related]
14. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Manome Y, Watanabe M, Abe T, Tomita M, Watanabe S, Yokokawa Y, Takahashi Y, Ishii K, Kimura A, Murakami M, Nagata M, Shibata T, Nakamura M, Tanigawa N, Ohno T. Anticancer Res; 2001 Dec 01; 21(4A):2265-72. PubMed ID: 11724281 [Abstract] [Full Text] [Related]
15. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Chang JW, Lee H, Kim E, Lee Y, Chung SS, Kim JH. Neurosurgery; 2000 Oct 01; 47(4):931-8; discussion 938-9. PubMed ID: 11014433 [Abstract] [Full Text] [Related]
16. Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Rogulski KR, Zhang K, Kolozsvary A, Kim JH, Freytag SO. Clin Cancer Res; 1997 Nov 01; 3(11):2081-8. PubMed ID: 9815600 [Abstract] [Full Text] [Related]
17. Treatment of thyroid carcinoma cells with four different suicide gene/prodrug combinations in vitro. Nishihara E, Nagayama Y, Narimatsu M, Namba H, Watanabe M, Niwa M, Yamashita S. Anticancer Res; 1998 Nov 01; 18(3A):1521-5. PubMed ID: 9673364 [Abstract] [Full Text] [Related]
18. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Rogulski KR, Kim JH, Kim SH, Freytag SO. Hum Gene Ther; 1997 Jan 01; 8(1):73-85. PubMed ID: 8989997 [Abstract] [Full Text] [Related]
19. [Antitumor effects of cytosine deaminase and HSV-tk double suicide gene with adenovirus mediation on rectal cancer cells]. Li S, Yu B, An P. Zhonghua Wai Ke Za Zhi; 2001 Aug 01; 39(8):577-9. PubMed ID: 11758189 [Abstract] [Full Text] [Related]
20. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity. Corban-Wilhelm H, Becker G, Bauder-Wüst U, Greulich D, Debus J. Clin Exp Med; 2003 Nov 01; 3(3):150-6. PubMed ID: 14648229 [Abstract] [Full Text] [Related] Page: [Next] [New Search]